Target intelligence / Profile preview

Sirtuin 2-7 (SIRT2-7)

Target
SIRT2-7
Molecular classification
Enzyme, Histone modification, NAD+-dependent deacetylase, Deacylase
01

Overview

Sirtuin 2-7 (SIRT2-7) refers to a group of six mammalian sirtuins (SIRT2, SIRT3, SIRT4, SIRT5, SIRT6, and SIRT7) that belong to the sirtuin family of NAD+-dependent deacylases (1, 2). These enzymes are characterized by a conserved catalytic core and are localized to distinct cellular compartments: SIRT2 is primarily cytoplasmic; SIRT3, SIRT4, and SIRT5 are mitochondrial; and SIRT6 and SIRT7 are nuclear or nucleolar (2, 8). They regulate a wide array of biological processes, including metabolism, DNA repair, cell cycle progression, and stress responses, by removing acetyl, succinyl, malonyl, or other acyl groups from both histone and non-histone protein substrates (1, 16, 27). Due to their central roles in cellular homeostasis, SIRT2-7 are implicated in the pathogenesis of various diseases, such as cancer, neurodegenerative disorders (e.g., Parkinson's and Alzheimer's), and metabolic syndromes (3, 9, 11). Therapeutic strategies targeting these sirtuins involve the development of both small-molecule inhibitors and activators, though the context-dependent nature of their functions—acting as either tumor suppressors or promoters—poses significant challenges for clinical application (10, 15, 22).

Other names
Sirtuin family members 2-7SIR2-like proteins 2-7Class III histone deacetylases 2-7NAD-dependent protein deacetylases 2-7
02

Mechanism of action

NAD+-dependent deacetylation and deacylation of histone and non-histone proteins

03

Biological functions

MetabolismCell cycleApoptosisDNA repairStress responseAgingRibosome biogenesis
04

Disease associations

CancerNeurodegenerative diseaseMetabolic disorderInflammationInfection
05

Safety considerations

Dual role in tumorigenesis (tumor suppressor vs. promoter)Broad metabolic impactPotential for systemic toxicity due to ubiquitous expressionRisk of genomic instability with SIRT6 inhibition
06

Interacting drugs

Nicotinamide

8 more in the full profile.

07

Biomarkers

Acetylated alpha-tubulinAcetylated H3K9Acetylated H3K56Acetylated H3K18Acetylated SOD2Succinylated proteins

Beyond the preview

Go deeper on Sirtuin 2-7 (SIRT2-7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sirtuin 2-7 (SIRT2-7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call